In the complex world of drug development and manufacturing, excipients play a crucial but often overlooked role. These inactive ingredients are essential components of pharmaceutical formulations, serving various functions from improving drug stability…
The Critical Role of Excipient Purity in Pharmaceutical Formulations Read Post »
Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate […]
Source
How to Develop a Competitive Edge in Generic Drug Development Read Post »
To identify Key Starting Materials (KSMs) for Active Pharmaceutical Ingredients (APIs), pharmaceutical companies and regulatory bodies follow a systematic approach […]
Source
How to Find Key Starting Materials (KSMs) for Pharmaceutical APIs Read Post »
Top Biotechnology Innovations in 2024: A Year of Breakthroughs and Partnerships The biotechnology industry is poised for significant advancements in
The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the […]
Source
How to Navigate the Generic Drug Market Post-COVID Read Post »
Annual Drug Patent Expirations for IGALMI Igalmi is a drug marketed by Bioxcel and is included in one NDA. It […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the pharmaceutical companies with the most ointment dosed drugs. For a different perspective, see the most popular […]
Source
Which pharmaceutical companies have the most ointment dosed drugs? Read Post »
In the high-stakes world of pharmaceuticals, generic drugs have become the unsung heroes of healthcare accessibility. These cost-effective alternatives to […]
Source
The Regulatory Maze: How Generic Drugs Navigate FDA Approval Read Post »
The global pharmaceutical excipients market is projected to reach $10.6 billion by 2026, growing at a CAGR of 5.8% from 2021 to 2026. As pharmaceutical companies race to develop new liquid formulations, choosing the right excipients has become increasi…
Excipient Use in Liquid Formulations: Key Tips for Pharmaceutical Companies Read Post »
Get new actionable insights and updates from BiotechBlog
